American Healthcare REIT, Inc. (AHR) AI Stock Analysis

• Market Cap: $9.14B
• Dividend Yield: 2.1%
• Average Volume (3M): 2.64M
• Price to Earnings (P/E): 111.9
• Beta (1Y): 0.63
• Revenue Growth: 11.81%
• EPS Growth: N/A
• Country: US
• Employees: 114
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.06
• Shares Outstanding: 188,028,550
• 10 Day Avg. Volume: 3,345,718
• 30 Day Avg. Volume: 2,640,087
• PEG Ratio: -0.46
• Price to Book (P/B): 2.35
• Price to Sales (P/S): 3.46
• P/FCF Ratio: 47.11
• Enterprise Value/Market Cap: 1.15
• Enterprise Value/Revenue: 4.65
• Enterprise Value/Gross Profit: 30.61
• Enterprise Value/Ebitda: 32.79
• 1Y Price Target: $57.67
• Price Target Upside: 19.87% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 6
• EPS Forecast (FY): 0.77
• Revenue Forecast (FY): $2.64B

• Rating: 64 Neutral
• Price Target: $56.00 ▲(16.40% Upside)
• Action: Reiterated Date: 03/19/26
• Date: Action: Reiterated 03/19/26

AHR’s score is driven primarily by improving financial trajectory (better cash generation and de-risking balance-sheet signals) and strong earnings-call momentum with upbeat 2026 guidance. These positives are tempered by valuation risk from a very high P/E and some financial-statement consistency concerns that reduce confidence in the latest-year step-change improvement; technicals are supportive and help the overall score.

Positive Factors

Same-store NOI & occupancy momentum

Sustained double-digit same-store NOI growth and rising occupancies indicate durable demand and operating leverage in senior-health and SHOP assets. Higher occupancies (~90.6% for key segments) and payer-mix improvement support persistent cash NOI expansion and pricing power over multiple quarters.

Active, accretive capital deployment

High, relationship-sourced deal flow and large 2025 investment activity demonstrate a repeatable acquisition pipeline and scale advantages. Targeting higher-acuity, newer assets and limited new supply supports accretive growth, diversification and long-term NOI upside if integration executes as planned.

Improving cash generation and de-risked balance sheet

Consistent positive operating cash flow and a sustained free cash flow turnaround through 2024–2025 enhance funding flexibility for acquisitions, development and distributions. Improved cash conversion reduces refinancing pressure and makes the business less reliant on volatility-prone capital markets.

Negative Factors

Volatile profitability and inconsistent 2025 margins

Large swings from multi-year net losses to outsized 2025 margins raise questions about the sustainability and quality of earnings. Inconsistent reported margin math and atypical 2025 figures impair trend analysis and increase the risk that recent profitability is episodic or driven by non-recurring items.

Balance-sheet reporting & leverage caveats

An abrupt reported debt reduction and the exclusion of unsettled forward equity from net-debt metrics reduce transparency. If forward agreements settle or reporting adjustments occur, leverage could reappear quickly, constraining financial flexibility and increasing refinancing or covenant risk.

Execution risk on value-add acquisitions

Significant value-add acquisition exposure requires sustained operational execution across operators and time to realize occupancy and RevPOR gains. With revenue-management still at pilot stage and rising competition compressing yields, execution shortfalls could delay cash flow accretion and elevate holding costs.

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company Description

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.

How the Company Makes Money

AHR generates revenue primarily through rental income from its portfolio of healthcare properties leased to various tenants, including healthcare providers and operators. The company's revenue model is based on long-term leases, which typically provide stable and predictable cash flows. Key revenue streams include base rental payments, percentage rents, and reimbursement for property operating expenses. Additionally, AHR may benefit from property appreciation and strategic acquisitions. Partnerships with healthcare operators and providers can enhance occupancy rates and tenant stability, further contributing to its earnings.

American Healthcare REIT, Inc. Financial Statement Overview

Summary

Financial statements show steady multi-year revenue growth, improving leverage trends into 2024, and stronger operating/free cash flow in 2024–2025. Offsetting this, profitability was inconsistent with net losses in 2021–2024, and there are noted 2025 data consistency red flags (margins and an abrupt debt shift) that reduce confidence in the apparent step-change improvement.

Income Statement

Revenue has grown steadily from 2020–2024 (with positive growth each year from 2021 onward), supporting improving scale. Profitability, however, has been volatile: the company reported net losses from 2021–2024, before a sharp swing to strong profitability in 2025. The 2025 margin figures appear inconsistent (gross profit and EBITDA are far larger than revenue), which reduces confidence in the quality/interpretability of the latest-year margin profile. Overall, improving top-line trajectory and a major 2025 rebound are positives, but earnings stability is a clear historical weakness.

Balance Sheet

Leverage improved meaningfully over time, with debt-to-equity declining from elevated levels in 2022–2023 to a moderate level in 2024, and reported total debt dropping to zero in 2025—this is a major strengthening if accurate. Equity also increased versus 2023, improving balance-sheet cushioning. The key weakness is historical leverage (notably 2022–2023) and the abrupt 2025 debt shift, which is unusual and warrants caution when interpreting trend quality.

Cash Flow

Operating cash flow is consistently positive in most years and improved into 2024–2025, with free cash flow turning solidly positive in 2024 and remaining strong in 2025. Free cash flow growth was very strong in 2024, and 2025 shows free cash flow roughly matching net income, indicating improved cash conversion. Weak spots include negative free cash flow in 2021 and 2023 and uneven coverage of obligations in earlier years, highlighting prior volatility in cash generation.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.26B	2.07B	1.86B	1.62B	1.26B
Gross Profit	39.69M	416.77M	356.83M	335.97M	182.01M
EBITDA	321.98M	315.48M	324.26M	233.76M	159.43M
Net Income	69.81M	-37.81M	-71.47M	-81.30M	-47.79M
Balance Sheet
Total Assets	5.43B	4.49B	4.58B	4.79B	4.58B
Cash, Cash Equivalents and Short-Term Investments	114.84M	76.70M	43.45M	65.05M	81.60M
Total Debt	1.59B	1.87B	3.02B	2.83B	2.50B
Total Liabilities	2.07B	2.18B	3.12B	3.14B	2.75B
Stockholders Equity	3.32B	2.26B	1.27B	1.40B	1.58B
Cash Flow
Free Cash Flow	165.88M	84.15M	-1.26M	76.25M	-61.78M
Operating Cash Flow	294.44M	176.09M	98.53M	147.77M	17.91M
Investing Cash Flow	-1.08B	-8.73M	9.40M	-118.58M	-138.65M
Financing Cash Flow	817.50M	-134.74M	-129.06M	-42.92M	94.11M

American Healthcare REIT, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 48.11
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Negative. The current price of 48.11 is below the 20-day moving average (MA) of 52.21, below the 50-day MA of 50.05, and above the 200-day MA of 44.25, indicating a neutral trend. The MACD of 0.15 indicates Positive momentum. The RSI at 32.95 is Neutral, neither overbought nor oversold. The STOCH value of 26.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AHR.

American Healthcare REIT, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	77 Outperform	$8.06B	18.09	8.99%	3.56%	59.25%	88.37%
OHI	74 Outperform	$13.24B	22.25	11.83%	6.11%	13.50%	31.56%
NHI	70 Outperform	$3.97B	25.18	9.63%	4.73%	8.04%	9.20%
SBRA	70 Outperform	$4.94B	29.37	5.63%	6.47%	8.12%	75.95%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
AHR	64 Neutral	$9.14B	111.95	2.61%	2.10%	11.81%	―
HR	64 Neutral	$6.01B	-24.09	-5.13%	6.56%	-6.59%	33.35%

American Healthcare REIT, Inc. Corporate Events

American Healthcare REIT Declares First-Quarter 2026 Cash Distribution

On March 18, 2026, American Healthcare REIT, Inc. announced that its board of directors declared a quarterly cash distribution of $0.25 per share for the first quarter of 2026, covering the period from January 1 to March 31. The distribution, equivalent to an annualized rate of $1.00 per share, will be paid on or about April 17, 2026, to common stockholders of record as of the close of business on March 31, 2026, underscoring the REIT’s ongoing capital return to shareholders from legally available funds.

The decision to maintain a defined quarterly cash payout signals continued confidence by American Healthcare REIT’s board in the company’s cash flow generation from its healthcare real estate portfolio. This distribution policy may appeal to income-focused investors seeking stable returns from the healthcare real estate sector, and it highlights the REIT’s commitment to providing predictable shareholder distributions tied to its operating performance.

The most recent analyst rating on (AHR) stock is a Buy with a $57.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Launches New $1.75 Billion ATM Program

On February 27, 2026, American Healthcare REIT, Inc. and its operating partnership entered into a new at-the-market equity offering sales agreement with a syndicate of major investment banks, enabling the company to sell up to $1.75 billion of common stock from time to time. Concurrently, the company terminated its prior ATM program, which still had about $230.1 million of unsold capacity, and set agent commissions at up to 2% of gross sales proceeds, with flexibility for negotiated, block, and exchange-based transactions.

The structure also allows for forward sale agreements with designated banks acting as forward purchasers, under which shares may be borrowed and sold to hedge forward exposure, with pricing adjusted for interest and expected dividends. The company plans to contribute net proceeds from any issuances and forward settlements to its operating partnership for units redeemable into common stock, to be used for general corporate purposes such as debt repayment, working capital, capital expenditures, and potential future investments, enhancing balance-sheet flexibility and funding optionality.

The most recent analyst rating on (AHR) stock is a Buy with a $55.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Reports Strong Q4 and 2025 Results

American Healthcare REIT on February 26, 2026 reported GAAP net income attributable to controlling interest of $10.8 million, or $0.06 per diluted share, for the fourth quarter of 2025 and $69.8 million, or $0.42 per diluted share, for full-year 2025, alongside Normalized FFO of $0.46 and $1.72 per diluted share for the quarter and year, respectively. The company posted total portfolio same-store NOI growth of 11.8% in the fourth quarter and 14.2% for 2025, driven by its integrated senior health campuses and senior housing operating properties, which delivered same-store NOI gains exceeding 14% for the quarter and 18% for the year.

In 2025 AHR invested over $950 million in new assets across its ISHC and SHOP segments and sold two non-core properties for $3.9 million, while subsequent to year-end it acquired five additional SHOP assets for about $117.5 million in California and Missouri. As of December 31, 2025, the REIT reported a $178 million in-process development and expansion pipeline, total consolidated indebtedness of $1.54 billion, liquidity of approximately $1.14 billion and an improved Net Debt-to-Annualized Adjusted EBITDA ratio of 3.4x, underscoring a balance of aggressive growth in senior care real estate with a moderately leveraged balance sheet.

The most recent analyst rating on (AHR) stock is a Buy with a $55.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Names Interim CEO During Medical Leave

On February 4, 2026, American Healthcare REIT disclosed that Chief Executive Officer and President Danny Prosky took a medical leave effective February 3, 2026, with Board Chairman Jeffrey T. Hanson stepping in as interim CEO and president to maintain operational continuity alongside the established leadership team. The company emphasized its seasoned executives and ongoing commitment to its strategic objectives, underscoring confidence in uninterrupted operations despite the temporary leadership change.

The most recent analyst rating on (AHR) stock is a Buy with a $55.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.